Unaudited NAV for March 2023 (1608427)
April 17 2023 - 1:00AM
UK Regulatory
Arix Bioscience PLC (ARIX) Unaudited NAV for March 2023
17-Apr-2023 / 07:00 GMT/BST
-----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
Unaudited NAV for March 2023
LONDON, 17 April 2023: Arix Bioscience plc ("Arix" or the
"Company") (LSE: ARIX), a transatlantic venture capital company
focused on investing in breakthrough biotechnology companies,
announces the unaudited Net Asset Value ("NAV") of the Company for
the date ended 31 March 2023 as follows:
NAV Breakdown
Date Total NAV
Listed Portfolio Unlisted Portfolio Cash Other Interests NAV per share
31 March 2023
GBP42.9m GBP66.6m GBP108.7m GBP3.1m GBP221.3m GBP1.71
(unaudited)
[ENDS]
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
+44 (0)20 7290 1050
ir@arixbioscience.com
Powerscourt Group
Sarah MacLeod, Ibrahim Khalil, Nick Johnson
+44 (0)20 7250 1446
arix@powerscourt-group.com
About Arix Bioscience plc
Arix Bioscience plc is a transatlantic venture capital company
focused on investing in breakthrough biotechnology companies around
cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the
capital, expertise, and global networks to help accelerate their
ideas into important new treatments for patients. As a listed
company, we are able to bring this exciting growth phase of our
industry to a broader range of investors.
www.arixbioscience.com
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: MSCL
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 237106
EQS News ID: 1608427
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1608427&application_name=news
(END) Dow Jones Newswires
April 17, 2023 02:00 ET (06:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Jan 2024 to Jan 2025